Current evidence of integrative oncology modalities for managing adverse effects and survivorship issues among adolescents and young adult (AYA) cancer patients and survivors
Author:
Affiliation:
1. Department of Clinical Pharmacy Practice, School of Pharmacy & Pharmaceutical Sciences, University of California, Irvine
2. Division of Oncology, Children's Hospital of Orange County, Orange, USA
Abstract
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference47 articles.
1. What should the age range be for AYA oncology?;J Adolesc Young Adult Oncol,2011
2. Age-specific patient navigation preferences among adolescents and young adults with cancer;Pannier;J Cancer Educ,2019
3. Cancer in young adults 20 to 39 years of age: overview;Bleyer;Semin Oncol,2009
4. Incidence, survival, and mortality trends of cancers diagnosed in adolescents and young adults (15–39 years): a population-based study in The Netherlands 1990–2016;van der Meer;Cancers (Basel),2020
5. Radiation-associated cardiovascular disease;Adams;Crit Rev Oncol Hematol,2003
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3